Reply SpA Stock
Price
Target price
€120.70
€120.70
-1.070%
-1.3
-1.070%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Loading data...
Your prediction
Reply SpA Stock
We can see a decrease in the price for Reply SpA. Compared to yesterday it has lost -€1.300 (-1.070%).
Pros and Cons of Reply SpA in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
S********** s********
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Reply SpA vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Reply SpA | -1.070% | -5.629% | -15.239% | -9.791% | -22.028% | -12.473% | 43.948% |
Txt E-Solutions | -1.610% | -7.716% | -12.482% | 30.901% | -13.475% | 145.572% | 279.826% |
Netsol Technologies | 2.890% | 3.488% | 10.559% | 52.137% | 40.157% | 12.658% | 41.270% |
Sohu.com Inc. | -0.750% | 1.538% | 4.762% | -2.941% | 2.326% | -23.220% | -20.000% |
News

Reply S.p.A.: the Board of Directors Approves the Half-Year Financial Report as of 30 June 2025
Today, the Board of Directors of Reply S.p.A. [EXM, STAR: REY] approved the results as at 30 June 2025.
Since the start of the year, the Group has recorded a consolidated turnover of €1,210.1

EQS-News: Reply: The Board of Directors approves the half-year financial report as of 30 June 2025
EQS-News: Reply: The Board of Directors approves the half-year financial report as of 30 June 2025

Reply Stock: AI Solution Transforms Breast Cancer Screening
Reply's subsidiary, Laife Reply, has partnered with the European Institute of Oncology (IEO) to develop a groundbreaking AI platform for mammography diagnostics. The solution, called X-RAIS